YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Merck to acquire Cidara

Posted online

Merck & Co. has agreed to acquire Cidara Therapeutics Inc. in a deal valued at $9.2 billion.

Bloomberg reports the deal is part of Merck & Co.'s ongoing efforts to make up for an upcoming patent loss of cancer drug Keytruda.

Cidara is a biotech company developing a flu treatment.

Read more from Bloomberg.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Transportation officials discuss $471M Forward 44 initiative

Project work in Springfield corridor will continue into 2031.

Most Read
Update cookies preferences